skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

In the developing pharma landscape, it’s important to consider all variables to create a winning portfolio strategy. To support the development of your own successful portfolio strategy, Pharma Intelligence invites you to watch our webinar: “Where is the pharma industry maximizing value?”, filmed on Tuesday May 23, 2017, presented by Datamonitor Healthcare Principal Analyst, Amanda Micklus.


This webinar focuses on the state of the pharma industry regarding long-term portfolio planning from the R&D stage through externalization and commercialization. Covered topics include:


Business development trends, including - internal R&D spending (including productivity measurements). What are the factors contributing to the projected sharp CAGR decline through 2020? Who shows most success with new product launches, and why?


Licensing and deal-making - How does pharma complement internal R&D with external business development deals? Find out by volume, value, phase, and therapy area.


Revenue trends – How do we view R&D investment and licensing/deal-making through the lens of revenue? Compare companies in Big Pharma, Mid Pharma, and Japan Pharma in terms of internal R&D product revenue versus that from external products.








電話:+81 (0)3 6273 4260